- Home
- NBIX vs BSY Comparison
NBIX vs BSY Comparison
Compare NBIX & BSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | BSY |
|---|---|---|
| Founded | 1992 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 13.1B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NBIX | BSY |
|---|---|---|
| Price | $142.31 | $39.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | ★ $176.19 | $56.73 |
| AVG Volume (30 Days) | 977.3K | ★ 2.0M |
| Earning Date | 02-05-2026 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | 0.83 |
| Revenue | ★ $2,682,700,000.00 | $1,460,019,000.00 |
| Revenue This Year | $23.76 | $11.30 |
| Revenue Next Year | $18.01 | $10.23 |
| P/E Ratio | ★ $33.80 | $48.42 |
| Revenue Growth | ★ 19.61 | 11.12 |
| 52 Week Low | $84.23 | $36.51 |
| 52 Week High | $160.18 | $59.25 |
Technical Indicators
Market Signals| Indicator | NBIX | BSY |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 29.86 |
| Support Level | $151.09 | $39.90 |
| Resistance Level | $155.55 | $40.77 |
| Average True Range (ATR) | 4.52 | 0.93 |
| MACD | -1.41 | 0.11 |
| Stochastic Oscillator | 5.75 | 4.40 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About BSY Bentley Systems Incorporated Class B
Bentley Systems is a software vendor that caters to engineers, architects, constructors, and geospatial professionals by enabling design, modeling, simulation, project management, and data management of infrastructure assets. The firm delivers solutions via the cloud, desktop, and hybrid environments. While Bentley is relatively small in comparison with peers like Autodesk, it shines in core specialty areas, like bridge or rail design, as opposed to being more broad-based in its applications. Bentley's largest end market is the public works and utilities sector, which represents approximately two thirds of revenue.